The concurrent use of N- and C-terminal antibodies anti-nucleophosmin 1 in immunofluorescence experiments allows for precise assessment of its subcellular localisation in acute myeloid leukaemia patients

Leukemia. 2012 Jan;26(1):159-62. doi: 10.1038/leu.2011.177. Epub 2011 Jul 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies / immunology*
  • Fluorescent Antibody Technique
  • Humans
  • Leukemia, Myeloid, Acute / metabolism*
  • Leukemia, Myeloid, Acute / pathology
  • Nuclear Proteins / immunology*
  • Nucleophosmin
  • Subcellular Fractions / immunology*

Substances

  • Autoantibodies
  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin